57 trends tracked about this subject — the full history, oldest to newest below.
Dietitians say eating cruciferous vegetables such as broccoli may lower pancreatic cancer risk, with one study linking more than three-quarters of a cup per week to significantly lower odds of diagnosis.
An investigational KRAS vaccine targeting pancreatic cancer has triggered a robust immune response in a phase 2 trial, positioning vaccines as a potential new frontier in KRAS-directed therapy.
MedPacto reported that its experimental drug MP010 eliminated 75% to 87.5% of aggressive pancreatic tumors in mice.
Mutant KRAS G12D vaccination emerges as a focal point for pancreatic cancer interception, with researchers probing why this specific mutation triggers immune responses that could enable preventive strategies.
A gastroenterologist's warning that post-meal indigestion could signal early pancreatic cancer is driving a wave of awareness coverage across U.S. and Australian outlets.
Recent coverage highlights an experimental pancreatic cancer vaccine showing promise in a clinical trial.
A local woman begins a groundbreaking new pancreatic cancer treatment as emerging therapies gain wider media attention.
Revolution Medicines' pancreatic cancer drug Rasonque achieves an eye-popping commercial debut, shattering analyst estimates.
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
18 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
An experimental mRNA vaccine targeting KRAS mutations triggered immune responses in 99% of pancreatic cancer patients in recent Phase 2 study results.
Incyte presents new early clinical data at ESMO for its KRAS G12D-targeted pancreatic and colorectal cancer medicine.
Artificial intelligence tools are leveraging routine CT scans to spot hidden pancreatic cancer indicators years prior to diagnosis.
Daraxonrasib enters clinical focus as a game-changing new treatment for metastatic pancreatic cancer.
Verastem advances its experimental KRAS inhibitor to Phase III following positive early data and a major funding round.
Recent coverage highlights new single-cell profiling insights into clonal heterogeneity and treatment resistance in pancreatic cancer.
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent coverage examines how scientists cracked the RAS mutation in pancreatic cancer and explores Arizona connections to the breakthrough treatment.
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent coverage details a major milestone in pancreatic cancer treatment with the approval of daraxonrasib and new laboratory breakthroughs.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent studies detail an mRNA immunotherapy strategy that reportedly leads to pancreatic cancer disappearing in mice.
Researchers are testing an emerging blood test aimed at catching pancreatic cancer before symptoms appear.
A newly evaluated blood test shows potential for detecting early-stage pancreatic cancer, according to recent medical studies.
An object initially mistaken for a rock turned out to be an immaculate mastodon tooth fossil, according to recent media coverage.
13 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
A breakthrough pancreatic cancer drug wins FDA approval and hits the clinic, raising questions over patient access.
A breakthrough pancreatic cancer drug called daraxonrasib has marked a major advance in care, though access remains a challenge.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
The FDA has approved daraxonrasib for the treatment of previously treated RAS-mutant non-small-cell lung cancer and pancreatic cancer.
The FDA approval of a landmark pancreatic cancer drug costing $480,000 annually signals a shifting economic landscape for oncology treatments.
Recent FDA approval of daraxonrasib for metastatic pancreatic cancer brings new hope to patients and clinicians alike.
13 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
8 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
A novel pancreatic cancer drug is drawing widespread attention from medical professionals, patients, and national media outlets alike.
Pancreatic cancer specialists are focusing on the new drug daraxonrasib as multiple hospitals join a national initiative.
10 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Scientific testing is currently underway on new vaccines designed to intercept hereditary colon and pancreatic cancers.
The family of Oscar winners Ben and Casey Affleck is mourning the loss of their mother, Chris Anne Affleck, following a battle with pancreatic cancer.
Chris Affleck, civil rights organizer and mother of Oscar winners Ben and Casey Affleck, has died at 83.
A mutant KRAS vaccine yields early positive results in its first human clinical trial for high-risk pancreatic cancer patients.
A Johns Hopkins surgeon reveals an AI breakthrough capable of detecting pancreatic cancer earlier than human physicians.
A new whole-blood mRNA diagnostic test has demonstrated the ability to detect 90% of early-stage pancreatic cancers, a disease with a 13% survival rate.
A Johns Hopkins-developed KRAS vaccine has demonstrated safety and durable immune responses in a trial focused on preventing pancreatic cancer in high-risk individuals.
A new modular in vivo antibody-ADC click chemistry approach aims to reverse drug resistance in tumors, including pancreatic cancer.
A new pill-based treatment targeting KRAS-mutated pancreatic cancer is generating expert excitement and hope for patient longevity.
The European Medicines Agency has fast-tracked the review of an experimental pancreatic cancer pill amid reports of significant clinical trial outcomes.
A Harvard gastroenterologist has identified seven silent symptoms of pancreatic cancer that serve as critical warning signs for early detection.
Researchers have discovered a drug that blocks 90% of pancreatic cancer cell migration in lab tests by triggering cellular self-destruction.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
9 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Pancreatic cancer treatment breakthrough sparks global medical and investment buzz